- Fund Type: Open-End Fund
- Objective: Global Equity
- Asset Class: Equity
- Geographic Focus: Global
Snapshot for Alfred Berg Global/Finland (ALFGLBA)
| Year To Date: | - | 3-Month: | +8.68% | 3-Year: | +7.07% | 52-Week Range: | 59.40 - 70.20 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +5.89% | 1-Year: | +10.57% | 5-Year: | +3.47% | Beta vs MXWO: | 0.72 |
Fund Profile & Information for ALFGLBA
Alfred Berg Global is a unit trust registered in Finland. The Trust's objective is capital appreciation. The Trust invests in equity and equity related securities worldwide.
| Inception Date: | 03-01-2001 | Telephone: | 35-8-9-22832600 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.alfredberg.fi/rahasto | ||
Fundamentals for ALFGLBA
| NAV | - |
|---|---|
| Assets (M) | (on 2012-09-28) 19.76 |
| Fund Leveraged | N |
| Minimum Investment | 5,000.00 |
| Minimum Subsequent Investment | - |
Dividends for ALFGLBA
No dividends reported
Fees & Expenses for ALFGLBA
| Front Load | 1.00 |
|---|---|
| Back Load | 1.00 |
| Current Mgmt Fee | 1.80 |
| Redemption Fee | 1.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.80 |
Top Fund Holdings for ALFGLBA
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Royal Dutch Shell PLC | 3,231 | 86,573 | 2.344% |
| International Business Machine | 565 | 84,525 | 2.288% |
| GlaxoSmithKline PLC | 4,208 | 71,047 | 1.923% |
| Coca-Cola Co/The | 2,589 | 71,029 | 1.923% |
| Novo Nordisk A/S | 507 | 68,699 | 1.860% |
| CBS Corp | 2,167 | 66,603 | 1.803% |
| Mizuho Financial Group Inc | 44,700 | 66,034 | 1.788% |
| AstraZeneca PLC | 1,688 | 60,193 | 1.630% |
| Australia & New Zealand Bankin | 2,902 | 59,271 | 1.605% |
| Total SA | 1,450 | 57,899 | 1.567% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page